Overview

Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Resolute Stents Implantation; C-MODE Trial

Status:
Not yet recruiting

Trial end date:
2025-07-10

Target enrollment:

Participant gender:

Summary

Previous randomized clinical trials have deomonstrated the efficacy and safety of short-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), however, the single antiplatelet agent to be maintained after short-term DAPT was different. Therefore, which antiplatelet agent to be maintained after short-term DAPT needs further invstigations.

Phase:

N/A

Details

Lead Sponsor:

Yonsei University

Treatments:

Aspirin
Clopidogrel